focus -WSS

focus

author：leisure time 2025-08-24 09:37:47 - browse：47849

Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT — Alex Hogan/STAT

Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

focus

WSS

ProMED, early warning system on disease outbreaks, in peril

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Stem cell clinics for heart failure: buyer be wary

Microsoft strikes partnership with Duke Health to advance health AI

hotspot

focus

focus

How one medical school became remarkably diverse

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Anesthesiologist group: stop taking Ozempic before surgery

Lung cancer screening guidelines updated for cigarette smokers

Continuity nursing helped my family in our darkest PICU moments

White House drug shortage group privately met with industry

Heart attack and stroke risk calculators need revising

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Trump demands the U.S. pay no more for drugs than other countries … again

TytoCare raises $49 million to build out AI

focus

Lung cancer screening guidelines updated for cigarette smokers

Live blog: Hearing on CRISPR

The drug industry sees a key ally in the Senate prevail

OTC birth control: A brief history of over the counter pill design

Humans aren't the only ones with an imagination. Rats have it too

Coloradans with cystic fibrosis could lose access to Trikafta

hotspot

focus

Wikipedia

knowledge